Visualizar Tese - Instituto de Biociências - Unesp

Cirilo, PDRREFERÊNCIAS222Mitra R, Lee J, Jo J et al. Prediction of Postoperative Recurrence-Free Survival in Non-Small CellLung Cancer by Using an Internationally Validated Gene Expression Model. Clin Cancer Res,17, 2934-2946, 2011.Mittal KR, Chen F, Wei JJ et al. Molecular and immunohistochemical evidence for the origin ofuterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas.Mod Pathol, 22, 1303–1311, 2009.Mittal KR and Joutovsky A. Areas with benign morphologic and immunohistochemical features areassociated with some uterine leiomyosarcomas. Gynecol Oncol, 104, 362–365, 2007.Mittal KR, Popiolek D, Demopoulos RI. Uterine myxoid leiomyosarcoma within a leiomyoma. HumPathol, 31, 398–400, 2000.Mizuochi T, Kimura A, Ueki I et al. Molecular genetic and bile acid profiles in two Japanese patientswith 3beta-hydroxy-DELTA5-C27-steroid dehydrogenase/isomerase deficiency. Pediatr Res,68, 258-263, 2010.Mo R, Rao SM, Zhu YJ. Identification of the MLL2 complex as a coactivator for estrogen receptoralpha. J Biol Chem, 281, 15714-15720, 2006.Mok SC, Bonome T, Vathipadiekal V et al. A gene signature predictive for outcome in advancedovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell,16, 521-532, 2009.Moore AB, Yu L, Swartz CD et al. Human uterine leiomyoma-derived fibroblasts stimulate uterineleiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF betareceptor signaling in coculture. Cell Commun Signal, 10, 8-10, 2010.Moore SD, Herrick SR, Ince TA et al. Uterine leiomyomata with t(10;17) disrupt the histoneacetyltransferase MORF. Cancer Res, 64, 5570–5577, 2004.Moorehead ME and Conard CJ. Uterine leiomyomas: a treatable condition. Ann N Y Acad Sci, 948,21-29, 2001.Müller M, Beck IM, Gadesmann J et al. MMP19 is upregulated during melanoma progression andincreases invasion of melanoma cells. Mod Pathol, 23, 511-521, 2010.Murnane JP. Telomere loss as a mechanism for chromosome instability in human cancer. CancerRes, 70, 4255-4259, 2010.Mylonas I, Brüning A, Shabani N et al. Evidence of inhibin/activin subunit betaC and betaE synthesisin normal human endometrial tissue. Reprod Biol Endocrinol, 19, 143, 2010.Nabokikh A, Ilhan A, Bilban M et al. Reduced TGF-beta1 expression and its target genes in humaninsulinomas. Exp Clin Endocrinol Diabetes, 115, 674-682, 2007.Napoli JL. Biochemical pathways of retinoid transport, metabolism, and signal transduction. ClinImmunol Immunopathol, 80, 52–62, 1996.